{"schema":"hottub-news/story/v1","story":"st_qvwfbu3hqhmwyiffgi4a","title":"New diabetes pill orforglipron achieves uniform weight loss for women of all ages","title_en":null,"outlets":2,"brief":null,"page":"https://hottub.news/stories/new-diabetes-pill-orforglipron-achieves-uniform-weight-loss-for-women-qvwfbu3hqh","count":2,"items":[{"id":"n_ihvlhe6vjc2gbvm2eunq","seq":405706,"kind":"article","title":"La nouvelle pilule contre le diabète, l’orforglipron, permet une perte de poids uniforme pour les femmes de tous âges","title_en":"The new diabetes pill, orforglipron, allows uniform weight loss for women of all ages","url":"https://ma-clinique.fr/la-nouvelle-pilule-contre-le-diabete-lorforglipron-permet-une-perte-de-poids-uniforme-pour-les-femmes-de-tous-ages","summary":"De nouvelles analyses qui seront présentées lors de la réunion annuelle de l’Association européenne pour l’étude du diabète (EASD) à Milan, en Italie (28 septembre – 2 octobre) montrent que le nouveau médicament oral quotidien pour la perte de poids/diabète de type 2, l’orforglipron, était associé à une perte de poids similaire chez les femmes […] L’article La nouvelle pilule contre le diabète, l’orforglipron, permet une perte de poids uniforme pour les femmes de tous âges…","published":"2026-09-28T10:20:21Z","seen":"2026-09-28T10:48:20Z","lang":"fr","source":{"id":"kite-ma-clinique-fr-31ebe5","name":"ma-clinique.fr","domain":"ma-clinique.fr"},"via":"kite-ma-clinique-fr-31ebe5","topics":["medicine","actualités médicales","nouvelle","contre","diabète","pilule","âgés","uniforme"],"authors":["Ma Clinique"],"story":"st_qvwfbu3hqhmwyiffgi4a","category":"health","category_p":0.699999988079071,"sentiment":"positive","tone":0.550000011920929,"political":0.019999999552965164},{"id":"n_qvwfbu3hqhmwyiffgi4a","seq":385705,"kind":"article","title":"New diabetes pill orforglipron achieves uniform weight loss for women of all ages","url":"https://www.news-medical.net/news/20260928/New-diabetes-pill-orforglipron-achieves-uniform-weight-loss-for-women-of-all-ages.aspx","summary":"New analyses to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) show that the new daily oral weight loss / type 2 diabetes medication orforglipron was associated with similar weight loss for women of different ages and at different life stages – premenopausal, experiencing menopause, or post-menopausal. The study is by Dr Hunter Thomas Hoffman, Eli Lilly and Company, Indianapolis, IN, USA – the…","published":"2026-09-28T08:48:00Z","seen":"2026-09-28T09:16:59Z","lang":"en","source":{"id":"kite-news-medical-net-491c44","name":"news-medical.net","domain":"news-medical.net"},"via":"kite-news-medical-net-491c44","topics":["medicine"],"entities":[{"id":"Q120491908","name":"orforglipron","type":"other"}],"image":"https://www.news-medical.net/image-handler/picture/2014/7/weight_loss-620x480.jpg","mentions":2,"story":"st_qvwfbu3hqhmwyiffgi4a","category":"health","category_p":0.7799999713897705,"sentiment":"positive","tone":0.5299999713897705,"political":0.019999999552965164}]}